Hummsa Biotech Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 4

Employees

  • Latest Deal Type
  • Early Stage VC
  • (Upcoming)

  • Investors
  • 7

Hummsa Biotech General Information

Description

Developer of a therapeutics platform designed to accelerate the discovery of regenerative metabolic drugs. The company offers in-licensed academic assets and artificial intelligence-driven discovery tools, enabling pharmaceutical researchers and clinicians to improve treatment options for metabolic disorders.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2/A Rakhal Mukherjee Road
  • Kolkata, West Bengal 700025
  • India
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2/A Rakhal Mukherjee Road
  • Kolkata, West Bengal 700025
  • India

Hummsa Biotech Timeline

2023202420252026
Date FoundedFinancing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Hummsa Biotech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Early Stage VC Upcoming Pre-Clinical Trials
6. Early Stage VC 30-Sep-2024 Completed Pre-Clinical Trials
5. Accelerator/Incubator Completed Pre-Clinical Trials
4. Accelerator/Incubator 01-Jun-2024 Completed Pre-Clinical Trials
3. Accelerator/Incubator 01-Mar-2023 Completed Pre-Clinical Trials
2. Accelerator/Incubator 01-Jan-2023 Completed Pre-Clinical Trials
1. Accelerator/Incubator Completed Pre-Clinical Trials
To view Hummsa Biotech’s complete valuation and funding history, request access »

Hummsa Biotech Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
CCPS
CCPS
Ordinary
Series 1 CCPS 2,001 $74.54 $74.54 1x $74.54 14.18%
Ordinary 226 $52.63 $52.63 1x $52.63 1.6%
To view Hummsa Biotech’s complete cap table history, request access »

Hummsa Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a therapeutics platform designed to accelerate the discovery of regenerative metabolic drugs. The company o
Drug Discovery
Kolkata, India
4 As of 2024

Berkeley, CA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Hummsa Biotech Competitors (1)

One of Hummsa Biotech’s competitors is Carmot Therapeutics, a Formerly VC-backed company based in Berkeley, CA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Carmot Therapeutics Formerly VC-backed Berkeley, CA
You’re viewing 1 of 1 competitors. Get the full list »

Hummsa Biotech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Hummsa Biotech Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds
Dholakia Ventures Venture Capital Minority
First Founder Investment Trust Venture Capital Minority
Randev Ventures Family Office Minority
100X.VC Venture Capital Minority
IIIT-H Foundation Accelerator/Incubator Minority
You’re viewing 5 of 7 investors. Get the full list »

Hummsa Biotech FAQs

  • When was Hummsa Biotech founded?

    Hummsa Biotech was founded in 2022.

  • Where is Hummsa Biotech headquartered?

    Hummsa Biotech is headquartered in Kolkata, India.

  • What is the size of Hummsa Biotech?

    Hummsa Biotech has 4 total employees.

  • What industry is Hummsa Biotech in?

    Hummsa Biotech’s primary industry is Drug Discovery.

  • Is Hummsa Biotech a private or public company?

    Hummsa Biotech is a Private company.

  • What is Hummsa Biotech’s current revenue?

    The current revenue for Hummsa Biotech is .

  • How much funding has Hummsa Biotech raised over time?

    Hummsa Biotech has raised $510K.

  • Who are Hummsa Biotech’s investors?

    Dholakia Ventures, First Founder Investment Trust, Randev Ventures, 100X.VC, and IIIT-H Foundation are 5 of 7 investors who have invested in Hummsa Biotech.

  • Who are Hummsa Biotech’s competitors?

    Carmot Therapeutics is a competitor of Hummsa Biotech.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process